Immediate Impact
1 by Nobel laureates 2 from Science/Nature 65 standout
Citing Papers
Transforming obesity: The advancement of multi-receptor drugs
2024 Standout
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
2023 Standout
Works of T William-Olsson being referenced
Orlistat (Ro 18-0647), a lipase inhibitor, in the treatment of human obesity: a multiple dose study.
1995
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| T William-Olsson | 62 | 62 | 157 | 142 | 109 | 7 | 374 | |
| Lisa Olsen | 57 | 88 | 178 | 205 | 174 | 14 | 456 | |
| Joyce E. Swanson | 45 | 46 | 93 | 199 | 254 | 9 | 447 | |
| Eric Nolen‐Doerr | 48 | 76 | 122 | 164 | 185 | 9 | 449 | |
| Steven H. Baron | 44 | 108 | 58 | 98 | 107 | 9 | 349 | |
| G. E. Hall | 33 | 51 | 124 | 122 | 80 | 5 | 410 | |
| Magalie Berthiaume | 45 | 141 | 61 | 149 | 248 | 8 | 404 | |
| Rema Moore | 33 | 86 | 199 | 101 | 107 | 15 | 398 | |
| C Berne | 88 | 65 | 45 | 173 | 102 | 19 | 427 | |
| T. B. Seaton | 43 | 39 | 144 | 131 | 249 | 6 | 426 | |
| Jinhua Yin | 28 | 69 | 61 | 132 | 108 | 10 | 407 |
All Works
Loading papers...